Branden A. Smeester

875 citations

18 papers · 641 indexed · h-index 12

Oncology top 10%
- CAR-T cell therapy research 3
Immunology
Cellular and Molecular Neuroscience top 10%
- Neuropeptides and Animal Physiology 5
Molecular Biology
- CRISPR and Genetic Engineering 3
- Pharmacological Receptor Mechanisms and Effects 2
Genetics
- Virus-based gene therapy research 2
Physiology
- Pain Mechanisms and Treatments 7
Psychiatry and Mental health
- Cancer, Stress, Anesthesia, and Immune Response 3
Complementary and alternative medicine
- Acupuncture Treatment Research Studies 2

Co-authors: Alvin J. Beitz Branden S. Moriarity Emily J. Pomeroy Beau R. Webber Mitchell G. Kluesner Walker S. Lahr Cara-lin Lonetree Mary M. Lunzer
Cited by: Oncology Immunology Cellular and Molecular Neuroscience
Journals: Proceedings of the National Academy of Sciences (1 paper)Nature Communications (3 papers)Oncogene (1 paper)
Partner nations: United States South Korea United Kingdom

In The Last Decade

Branden A. Smeester

18 papers receiving 628 citations

Peers

Countries citing papers authored by Branden A. Smeester

Since Specialization

Citations

This map shows the geographic impact of Branden A. Smeester's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Branden A. Smeester with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Branden A. Smeester more than expected).

Fields of papers citing papers by Branden A. Smeester

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Branden A. Smeester. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Branden A. Smeester. The network helps show where Branden A. Smeester may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Branden A. Smeester, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Branden A. Smeester Line = papers co-authored together Branden A. Smeester links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work
1	RAD-TGTs: high-throughput measurement of cellular mechanotype via rupture and delivery of DNA tension probes Nature Communications ·Matthew R. Pawlak,Adam T. Smiley,María Paz Ramírez,Marcus D. Kelly,Ghaidan A. Shamsan,Sarah M. Anderson,Branden A. Smeester,David A. Largaespada,David J. Odde,Wendy R. Gordon	2023	10
2	CRISPR-Cas9 cytidine and adenosine base editing of splice-sites mediates highly-efficient disruption of proteins in primary and immortalized cells Nature Communications ·Mitchell G. Kluesner,Walker S. Lahr,Cara-lin Lonetree,Branden A. Smeester,Xiaohong Qiu,Nicholas J. Slipek,Patricia Claudio-Vázquez,Samuel P. Pitzen,Emily J. Pomeroy,Madison J. Vignes,Samantha C. Lee,Samuel P. Bingea,Aneesha A. Andrew,Beau R. Webber,Branden S. Moriarity	2021	74
3	Implication of ZNF217 in Accelerating Tumor Development and Therapeutically Targeting ZNF217-Induced PI3K–AKT Signaling for the Treatment of Metastatic Osteosarcoma Molecular Cancer Therapeutics ·Branden A. Smeester,Garrett M. Draper,Nicholas J. Slipek,Alex T. Larsson,Natalie Stratton,Emily J. Pomeroy,Kelsie L. Becklin,Kenta Yamamoto,Kyle Williams,Kanut Laoharawee,Joseph J. Peterson,Juan E. Abrahante,Susan K. Rathe,Lauren J. Mills,Margaret R. Crosby,Wendy A. Hudson,Eric P. Rahrmann,David A. Largaespada,Branden S. Moriarity	2020	13
4	Breast Tumor Kinase (Brk/PTK6) Mediates Advanced Cancer Phenotypes via SH2-Domain Dependent Activation of RhoA and Aryl Hydrocarbon Receptor (AhR) Signaling Molecular Cancer Research ·Amy R. Dwyer,Carlos Perez Kerkvliet,Raisa I. Krutilina,Hilaire C. Playa,Deanna N. Parke,Warner A. Thomas,Branden A. Smeester,Branden S. Moriarity,Tiffany N. Seagroves,Carol A. Lange	2020	16
5	PLX3397 treatment inhibits constitutive CSF1R-induced oncogenic ERK signaling, reduces tumor growth, and metastatic burden in osteosarcoma Bone ·Branden A. Smeester,Nicholas J. Slipek,Emily J. Pomeroy,Kanut Laoharawee,Sara H. Osum,Alex T. Larsson,Kyle Williams,Natalie Stratton,Kenta Yamamoto,Joseph J. Peterson,Susan K. Rathe,Lauren J. Mills,Wendy A. Hudson,Margaret R. Crosby,Minjing Wang,Eric P. Rahrmann,Branden S. Moriarity,David A. Largaespada	2020	28
6	A Genetically Engineered Primary Human Natural Killer Cell Platform for Cancer Immunotherapy Molecular Therapy ·Emily J. Pomeroy,John Hunzeker,Mitchell G. Kluesner,Walker S. Lahr,Branden A. Smeester,Margaret R. Crosby,Cara-lin Lonetree,Kenta Yamamoto,Laura E. Bendzick,Jeffrey S. Miller,Melissa A. Geller,Bruce Walcheck,Martin Felices,Beau R. Webber,Timothy K. Starr,Branden S. Moriarity	2019	139
7	SEMA4C is a novel target to limit osteosarcoma growth, progression, and metastasis Oncogene ·Branden A. Smeester,Nicholas J. Slipek,Emily J. Pomeroy,Heather E. Bomberger,Ghaidan A. Shamsan,Joseph J. Peterson,Margaret R. Crosby,Garrett M. Draper,Kelsie L. Becklin,Eric P. Rahrmann,James B. McCarthy,David J. Odde,David K. Wood,David A. Largaespada,Branden S. Moriarity	2019	12
8	Highly efficient multiplex human T cell engineering without double-strand breaks using Cas9 base editors Nature Communications ·Beau R. Webber,Cara-lin Lonetree,Mitchell G. Kluesner,Matthew J. Johnson,Emily J. Pomeroy,Miechaleen D. Diers,Walker S. Lahr,Garrett M. Draper,Nicholas J. Slipek,Branden A. Smeester,Klaus N. Lovendahl,Amber McElroy,Wendy R. Gordon,Mark J. Osborn,Branden S. Moriarity	2019	155
9	Cancer Gene Discovery Utilizing Sleeping Beauty Transposon Mutagenesis Methods in molecular biology ·Kelsie L. Becklin,Branden A. Smeester,Branden S. Moriarity	2018	4
10	Human β-Defensin 1 and β-Defensin 3 (Mouse Ortholog mBD14) Function as Full Endogenous Agonists at Select Melanocortin Receptors Journal of Medicinal Chemistry ·Mark D. Ericson,Anamika Singh,Srinivasa R. Tala,Erica M. Haslach,Marvin L. Dirain,Jay W. Schaub,Viktor Flores,Natalie Eick,Cody J. Lensing,Katie T. Freeman,Branden A. Smeester,Danielle N. Adank,Stacey L. Wilber,Robert C. Speth,Carrie Haskell‐Luevano	2018	4
11	Spinal Sigma-1 Receptor-mediated Dephosphorylation of Astrocytic Aromatase Plays a Key Role in Formalin-induced Inflammatory Nociception Neuroscience ·Hoon-Seong Choi,Mi Ji Lee,Sheu‐Ran Choi,Branden A. Smeester,Alvin J. Beitz,Jang‐Hern Lee	2017	7
12	Influence of social interaction on nociceptive-induced changes in locomotor activity in a mouse model of acute inflammatory pain: Use of novel thermal assays Brain Research Bulletin ·Branden A. Smeester,Jang‐Hern Lee,Alvin J. Beitz	2017	8
13	The relationship of bone-tumor-induced spinal cord astrocyte activation and aromatase expression to mechanical hyperalgesia and cold hypersensitivity in intact female and ovariectomized mice Neuroscience ·Branden A. Smeester,E.E. O’Brien,K.S. Michlitsch,Jang‐Hern Lee,Alvin J. Beitz	2016	10
14	Colocalization of aromatase in spinal cord astrocytes: Differences in expression and relationship to mechanical and thermal hyperalgesia in murine models of a painful and a non-painful bone tumor Neuroscience ·E.E. O’Brien,Branden A. Smeester,K.S. Michlitsch,Jang‐Hern Lee,Alvin J. Beitz	2015	14
15	Targeting putative mu opioid/metabotropic glutamate receptor-5 heteromers produces potent antinociception in a chronic murine bone cancer model European Journal of Pharmacology ·Branden A. Smeester,Mary M. Lunzer,Eyup Akgün,Alvin J. Beitz,Philip S. Portoghese	2014	39
16	Ligands that interact with putative MOR-mGluR5 heteromer in mice with inflammatory pain produce potent antinociception Proceedings of the National Academy of Sciences ·Eyup Akgün,Muhammad I. Javed,Mary M. Lunzer,Branden A. Smeester,Alvin J. Beitz,Philip S. Portoghese	2013	77
17	The Effect of Electroacupuncture on Osteosarcoma Tumor Growth and Metastasis: Analysis of Different Treatment Regimens Evidence-based Complementary and Alternative Medicine ·Branden A. Smeester,Mona Al-Gizawiy,E.E. O’Brien,Marna E. Ericson,Jennifer L. Triemstra,Alvin J. Beitz	2013	15
18	Effects of Different Electroacupuncture Scheduling Regimens on Murine Bone Tumor-Induced Hyperalgesia: Sex Differences and Role of Inflammation Evidence-based Complementary and Alternative Medicine ·Branden A. Smeester,Mona Al-Gizawiy,Alvin J. Beitz	2012	16

About Branden A. Smeester

Branden A. Smeester is a scholar working on Cellular and Molecular Neuroscience, Behavioral Neuroscience and Physiology, having authored 18 papers that have together received 641 indexed citations. Recurring topics across this work include Pain Mechanisms and Treatments (7 papers), Neuropeptides and Animal Physiology (5 papers), CAR-T cell therapy research (3 papers), Cancer, Stress, Anesthesia, and Immune Response (3 papers), CRISPR and Genetic Engineering (3 papers), Virus-based gene therapy research (2 papers), Pharmacological Receptor Mechanisms and Effects (2 papers) and Acupuncture Treatment Research Studies (2 papers). The work is most often cited by research in Oncology (250 citations), Immunology (153 citations) and Cellular and Molecular Neuroscience (129 citations). Branden A. Smeester has collaborated with scholars based in United States, South Korea and United Kingdom. Frequent co-authors include Alvin J. Beitz, Branden S. Moriarity, Emily J. Pomeroy, Beau R. Webber, Mitchell G. Kluesner, Walker S. Lahr, Cara-lin Lonetree, Mary M. Lunzer, Philip S. Portoghese and Eyup Akgün. Their work appears in journals such as Proceedings of the National Academy of Sciences, Nature Communications and Oncogene.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact